Kingchem (Liaoning) Life Science Co., Ltd. (SHE:301509)

Market Cap	3.24B -31.6%
Revenue (ttm)	611.14M +11.3%
Net Income	74.03M +6.9%
EPS	0.62 +7.2%
Shares Out	120.45M
PE Ratio	43.49
Forward PE	n/a
Dividend	0.90 (3.35%)
Ex-Dividend Date	Jun 2, 2026

Volume	1,651,990
Open	26.81
Previous Close	26.88
Day's Range	26.68 - 27.28
52-Week Range	25.65 - 48.60
Beta	0.31
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About SHE:301509

Kingchem (Liaoning) Life Science Co., Ltd. engages in the provision of small molecule CDMO services in China and internationally. The company offers fluorine-containing products, such as benzene intermediates of trifluoromethoxy or trifluoromethyl groups, and fluoroaromatic intermediates. It also provides non-fluorinated products, including nitrogen-containing heterocyclic compounds, aliphatic organic derivatives of ammonia, carboxylic acids and their derivatives, alkenes, non-fluorinated halobenzenes, phenols, ketones, and isocyanates. The com...

• Industry: Pharmaceutical Preparations
• Founded: 2009
• Employees: 690
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301509

Financial Performance

In 2025, SHE:301509's revenue was 639.37 million, an increase of 28.64% compared to the previous year's 497.01 million. Earnings were 104.81 million, an increase of 171.46%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 3, 2026

Data Sources Report a data error